VYNE - VYNE Therapeutics Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.39 -0.01 (-1.28%)	0.0 (0.0%)	0.0 (0.0%)	0.0 (1.29%)	0.01 (2.59%)	-0.01 (-2.67%)	0.0 (0.03%)	0.0 (0.03%)

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.13
Diluted EPS:: -0.13
Basic P/E:: -2.9615
Diluted P/E:: -2.9615
RSI(14) 1m:: 100.0
VWAP:: 0.39
RVol:: 0.6211

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	0.39 -0.01 (-1.27%)	Oct 14 19:25
10m	Price decrease 10m	0.38 -0.01 (-3.77%)	Oct 14 18:07
10m	Price decrease 10m	0.38 -0.02 (-5.0%)	Oct 14 17:33
1m	Price increase 1m	0.41 +0.01 (+2.17%)	Oct 14 17:29
1m	Price increase 1m	0.41 +0.01 (+2.78%)	Oct 14 17:27